Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $15.61, but opened at $16.15. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $15.70, with a volume of 738 shares trading hands.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on TLX. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a report on Tuesday, November 19th. UBS Group began coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They issued a "buy" rating and a $21.00 target price for the company.
Get Our Latest Stock Report on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Stock Up 4.9 %
The stock's fifty day simple moving average is $15.61.
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Read More
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
